Skip to search formSkip to main contentSkip to account menu

Hepatitis B Surface Antigen Vaccine

Known as: Recombinant Hepatitis B Vaccine, hepatitis b vaccines, Hepatitis B Surface Antigen (rDNA) 
A non-infectious mixture containing recombinant hepatitis B surface antigen (HBsAg) in a liquid vehicle. Immunization with the hepatitis B vaccine… 
National Institutes of Health

Related topics

Related topics

24 relations
0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax]Actively Acquired Immunity [PE]

Narrower (11)

COMVAXEngerix-BGenHevac B PasteurGenHevac BTM

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Booster Vaccinations: Can Immunologic Memory Outpace Disease Pathogenesis?
Almost all current vaccines work by the induction of antibodies in serum or on the mucosa to block adherence of pathogens to… 
Highly Cited
1994
Highly Cited
1994
Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Immunization with soluble proteins only rarely induces a specific response of CD8+ CTL. We describe experiments that demonstrate… 
Highly Cited
1993
Highly Cited
1993
Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses
Accessory cell surface molecules, such as T cell antigen CD2 and its ligand lymphocyte function-associated antigen 3 (LFA-3; CD58… 
Highly Cited
1993
Highly Cited
1993
Relating structure to function in the hepatitis delta virus antigen
Hepatitis delta virus expresses two forms of a single protein, the small (delta Ag-S) and large (delta Ag-L) antigens, which are… 
Highly Cited
1989
Highly Cited
1989
Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
We report the development of two models for synthetic hepatitis B vaccines. The models were based on the multiple antigen peptide… 
Highly Cited
1989
Highly Cited
1989
Immunogenicity of peptide fusions to hepatitis B virus core antigen.
Several gene fusions have been constructed in which coding sequences for antigenic regions of the pre-S sequences of hepatitis B… 
Highly Cited
1987
Highly Cited
1987
Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein
P24, P30, and P39, the three major surface antigens of the envelope of hepatitis B virus, are co-carboxy-terminal proteins with… 
Highly Cited
1984
Highly Cited
1984
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Highly Cited
1984
Highly Cited
1984
Hepatitis-B vaccination in the elderly.
Highly Cited
1976
Highly Cited
1976
"e" Antigen, Dane particles, and serum DNA polymerase activity in HBsAg carriers.
Sera of 103 carriers of hepatitis B surface antigen were assayed for e-antigen and anti-e. Twenty-four were e-antigen-positive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)